BRIEF-Amgen says Analysis From Kyprolis Trial Published in Journal Of Clinical Oncology
Reuters Staff
1 Min Read
Jan 17 (Reuters) - Amgen Inc:
* OVERALL SURVIVAL ANALYSIS FROM KYPROLIS® (CARFILZOMIB) PHASE 3 ASPIRE TRIAL PUBLISHED IN THE JOURNAL OF CLINICAL ONCOLOGY Source text for Eikon: Further company coverage: